A technique dubbed the “Waterman Protocol” is garnering international attention for a Lake County doctor.
Dr. Lou Guzzi, critical care physician at AdventHealth Waterman in Tavares, was the lead author in a paper that looks at a new and fascinating way of determining kidney failure risks in ICU patients. The paper was published in June in Critical Care clinical medical journal.
Dr. Guzzi and his colleagues examined how the first Food and Drug Administration-approved biomarker test to assess risk for acute kidney injury is being used clinically, a news release states.
The doctor and the rest of the team invited a group of kidney experts to a panel discussion on the biomarker test. Specifically, the experts worked to identify which patients would be appropriate for testing, how the results should be interpreted and what actions would be taken based on the results.
The results from the panel discussion showed that clinical experts in Europe and North America have developed similar practices for using the biomarker test. Patients undergoing major surgery or patients with sepsis, as well as patients who are in crisis, tend to be a priority for testing kidney stress. For these patients who tested positive, managing fluids and drugs that are potentially toxic to the kidneys are a priority. Conversely, patients who tested negative were considered candidates for “fast-track” protocols, the release states.
Dr. Guzzi’s technique has been dubbed the “Waterman Protocol” and he has presented multiple lectures on this topic both in the United States and Europe.